1/24/23 - Benefits Pro

Horizon’s Joel White on the Impact 2022 had on Healthcare

 Read More
1/23/23 - Inside Health Policy

White House Reviews CMS Plan For Drug Pricing Demos; CMS, Drug Makers To Meet Second Time On IRA

 Read More
1/12/23 - Inside Drug Pricing

CMMI Weighs Value-Based Payment Demo For Drugs

 Read More
1/9/23 - Inside Health Policy

Lobbying On Drug Pricing To Span Multiple Areas Post-IRA

 Read More
1/3/23 - Inside Telehealth

Stakeholders Line Up Lobbying Priorities For Next Two Years

 Read More
1/3/23 - National Review

Horizon’s Research Highlighted in Inflation Reduction Act Reform Article

 Read More
11/15/22 - Inside Health Policy

Horizon’s Joel White Talks to Inside Health Policy about End-of-Year Medicaid Priorities

 Read More
11/8/22 - Fierce Healthcare

What a Divided Congress Could Mean for Healthcare in the Next Year

 Read More
10/15/22 - The Hill

HGA’s Joel White on Drug Pricing

 Read More
10/6/22 - Bloomberg Law

Horizon’s Brett Meeks Weighs In on NIH Director Appointment

 Read More
8/5/22 - The New York Times

HGA’s CEO Discusses Drug Costs with The New York Times

 Read More
placeholder image
5/23/22 - Bloomberg Government

Horizon Named a Top-Performing Lobbying Firm

 Read More

Search Horizon Government Affairs